Dilon Technologies has received CE Mark approval for the commercial sale of the Dilon 6800 gamma camera in EU member countries.

The Newport News, Va.–based Dilon said its system is a high-resolution gamma camera that enables molecular imaging of the breast and other small organs for early cancer detection.

“The body of clinical evidence related to our camera's performance and ability to detect tumors continues to mount; now medical professionals around the world will have access to the technology,” said Robert Moussa, chairman and CEO, Dilon.